Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MIX23 pseudogene 5 (MIX23P5) is annotated as a pseudogene of the MIX23 gene, which encodes mitochondrial matrix import factor 23, a protein involved in the import of proteins into the mitochondrial matrix in yeast and has a human homolog CCDC58. Pseudogenes like MIX23P5 are defective copies of genes that have lost their protein-coding potential through evolution, often due to mutations or deletions, and typically do not encode functional proteins. There is currently no evidence that MIX23P5 is transcribed, translated, or has any known biological function, involvement in disease, or therapeutic relevance. No known drugs interact with MIX23P5, and it is not considered a biomarker or associated with safety concerns. Its annotation as a pseudogene and the absence of confirmed biological or clinical functions make it an unsuitable target for therapeutic intervention.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MIX23 pseudogene 5 (MIX23P5).